Displaying items by tag: school of medicine

It may feel literally and figuratively that it is crunch time when it comes to getting summer-ready, but these UAB experts break down easy ways to make health a lifelong achievement beyond this season alone.
Heading to the great outdoors this summer? Here are some tips on how to stay safe in the wilderness or your own backyard.
Observations on depression with insight gleaned from the laboratory and the clinic are the focus of the third UAB Neuroscience Café at the Hoover Library.
Parkinson’s disease awareness is highlighted with official recognition from Alabama and the city of Birmingham in April.
The event will highlight genetic testing of embryos, the move toward transferring single embryos to avoid multiple births and UAB’s record success in IVF.
Biomarkers and new treatments for glaucoma are topics for the April 15 lecture.
In findings published April 9 in Science Translational Medicine, the UAB team describes the mechanism that contributes to persistent fibrosis in the aged, and suggests targets that may help reverse the buildup of scar tissue.
“The Biggest Loser” at-home winner to be present at the 2nd Annual Run 4 Mike, a fundraiser for UAB research in transverse myelitis and multiple sclerosis.
UAB researchers say new findings show that a herpes simplex virus therapy may be beneficial in treating malignant gliomas.

Nearly half of people living with HIV in the United States will be 50 or older by 2015, which places more emphasis on cognitive function research.

Michael Saag, M.D., helped transform the deadliest virus in human history into a manageable chronic disease, and he is now receiving a top honor.
The American Board of Emergency Medicine has created a new subspecialty for emergency physicians, and UAB’s Nafziger is a first to earn board certification.
UAB’s fourth-year medical students found out where they will do their residency training, and in what medical field, at the 2014 Match Day activities.
Tagged under
Landmark research for the surgical management of apical vaginal prolapse reveals comparable efficacy of sacrospinous ligament fixation and uterosacral ligament suspension, and that perioperative treatment is not indicated.
A grant for up to $35 million over five years has helped form the Antiviral Drug Discovery and Development Center.
Page 135 of 167